Literature DB >> 10530560

KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma.

V A Holst1, C E Marshall, C A Moskaluk, H F Frierson.   

Abstract

The c-kit proto-oncogene encodes a transmembrane receptor tyrosine kinase (KIT), which is expressed in several normal human tissues, especially mast cells and interstitial cells of Cajal. Expression of KIT has been noted in several types of neoplasms and gene mutation has been shown as a mechanism of c-kit oncogene activation in some tumors. Recently, a single adnexal adenoid cystic carcinoma (ACC) was reported to demonstrate KIT expression, however, examination of KIT expression or c-kit mutation in ACC of salivary glands has not been performed. We examined archival tissue samples from 30 ACC of major and minor salivary glands for KIT protein expression by immunohistochemistry with a polyclonal antibody and c-kit gene mutation by polymerase chain reaction amplification and DNA sequencing. KIT protein expression was noted in 90% of ACCs. An association between the presence of at least 50% KIT positive neoplastic cells and Grade 3 ACC or a solid growth pattern was observed (P < .05). KIT expression in normal or nonneoplastic salivary gland tissue was absent. No c-kit juxtamembrane domain (exon 11) or phosphotransferase domain (exon 17) mutations were found in any of the tumors examined. In conclusion, KIT protein expression is correlated with tumor grade of salivary ACC. However, gene mutation of exon 11 or exon 17 is not a mechanism of c-kit activation in these neoplasms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10530560

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  44 in total

Review 1.  Molecular biology of adenoid cystic carcinoma.

Authors:  Jia Liu; Chunbo Shao; Marietta L Tan; David Mu; Robert L Ferris; Patrick K Ha
Journal:  Head Neck       Date:  2011-10-17       Impact factor: 3.147

Review 2.  Genetic alterations in salivary gland cancers.

Authors:  Linda X Yin; Patrick K Ha
Journal:  Cancer       Date:  2016-02-29       Impact factor: 6.860

3.  [Salivary gland-like tumors of the breast].

Authors:  F Otterbach; K W Schmid
Journal:  Pathologe       Date:  2006-09       Impact factor: 1.011

Review 4.  Basaloid/blue salivary gland tumors.

Authors:  Raja R Seethala
Journal:  Mod Pathol       Date:  2017-01       Impact factor: 7.842

5.  Expression of miRNAs in adenoid cystic carcinomas of the breast and salivary glands.

Authors:  Orsolya Kiss; Anna-Mária Tőkés; Semir Vranic; Zoran Gatalica; László Vass; Nóra Udvarhelyi; A Marcell Szász; Janina Kulka
Journal:  Virchows Arch       Date:  2015-08-21       Impact factor: 4.064

Review 6.  Salivary gland-like tumours of the breast: surgical and molecular pathology.

Authors:  M Pia-Foschini; J S Reis-Filho; V Eusebi; S R Lakhani
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

Review 7.  Salivary gland carcinomas.

Authors:  Tobias Ettl; Stephan Schwarz-Furlan; Martin Gosau; Torsten E Reichert
Journal:  Oral Maxillofac Surg       Date:  2012-07-29

8.  Identification of c-kit gene mutations in primary adenoid cystic carcinoma of the salivary gland.

Authors:  Lizette Vila; Hongyan Liu; Samer Z Al-Quran; Dominique P Coco; Hui-Jia Dong; Chen Liu
Journal:  Mod Pathol       Date:  2009-07-17       Impact factor: 7.842

9.  Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors.

Authors:  S J Wong; T Karrison; D N Hayes; M S Kies; K J Cullen; T Tanvetyanon; A Argiris; N Takebe; D Lim; N F Saba; F P Worden; J Gilbert; H J Lenz; A R A Razak; J D Roberts; E E Vokes; E E W Cohen
Journal:  Ann Oncol       Date:  2015-11-23       Impact factor: 32.976

10.  Mitochondrial mutations in adenoid cystic carcinoma of the salivary glands.

Authors:  Suhail K Mithani; Chunbo Shao; Marietta Tan; Ian M Smith; Joseph A Califano; Adel K El-Naggar; Patrick K Ha
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.